Lexpos News

NHS England invites community pharmacy owners and teams to participate in user research on vaccination point-of-care solutions. The goal is to understand the decision-making process and gather insights into preferences and requirements for Point-of-Care solutions. Virtual sessions, lasting 20-30 minutes, offer an opportunity to share your views and suggestions. Interviews will be scheduled from 9th [...]

The post Share your views: Vaccination Point-of-Care solution appeared first on Community Pharmacy England.

A recorded presentation on the new funding and contractual arrangements for community pharmacies is now available to watch on-demand.  Following the announcement of the Community Pharmacy Contractual Framework (CPCF) settlement last week, Community Pharmacy England has been working around the clock to provide information, develop resources and answer your questions. Part of this work included [...]

The post Community Pharmacy England presents the new CPCF arrangements appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Synalar GEL 30g, Synalar GEL 60g,(fluocinoline acetonide 0.025%) Reig Jofre UK Drug alert number: EL(25)A/16 Date issued: 08 April 2025 It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of [...]

The post MHRA Class 2 Medicines Recall: Synalar GEL 30g & Synalar GEL 60g, (fluocinoline acetonide 0.025%) Reig Jofre UK appeared first on Community Pharmacy England.

The UK Health Security Agency (UKHSA) has launched a new campaign to help increase awareness of antimicrobial resistance (AMR). Targeted at younger adults, the campaign aims to build support for the behaviours that will help keep antibiotics working. Over the course of six weeks, the character ‘Andi Biotic’ will be popping up to make sure [...]

The post UKHSA launches new AMR awareness campaign appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection. MSN/2025/021 Tier 2 – medium impact Date of issue: 7th April 2025 Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection are being discontinued with stock [...]

The post Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection appeared first on Community Pharmacy England.